Onc Now | Episode 31
In this episode, Catherine Glass is joined by Anna Minchom, Clinical Scientist at the Drug Development Unit at the Royal Marsden Hospital and the Institute of Cancer Research, London, UK. In a highly informative discussion, Anna Minchom explains the drug development process, key considerations in designing and conducting a trial, and the challenges in drug resistance.
Apple | Spotify | Amazon Music | Youtube (19 mins)
Speaker bio:
Anna Minchom is a Clinical Scientist in the Drug Development Unit at the Royal Marsden Hospital and the Institute of Cancer Research, London. She works to develop novel drugs for the treatment of lung cancer through clinical trials and translational research and acts as principal investigator on national and international first-in-human clinical trials and phase II clinical trials.
Timestamps:
00:00 – Introduction
00:51 – Her journey into oncology
4:04 – Drug development
07:20 – Patient recruitment
08:45 – Challenges of drug resistance
11:20 – Early phase clinical trials
13:06 – Navigating clinical trial outcomes
15:38 – Emerging technologies and therapies
17:42 – Side effects
19:09 – Three magic wishes
Disclaimer: The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.
